Dr. Diego Jacinto Bedoya, MD

  • Huntsville, AL
  • Hematologist and oncologist
NPI1811134158PAC ID5799940607
Medicare services, 2024
55,601
Medicare patients, 2024
985
Part D claims, 2024
2,364
MIPS score, 2024
100
Hospital affiliations
4
Practice address
3601 Cci Dr Nw, Huntsville, AL 35805-2606
Practice phone
Call (256) 705-4224
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Clearview Cancer Institute

Multi-specialty group site · Huntsville, Alabama

See all 6 affiliations

Find Dr. Bedoya's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Diego Jacinto Bedoya is a hematologist and oncologist in Huntsville, Alabama

Dr. Bedoya practices at Clearview Cancer Institute in Huntsville, Alabama.

Dr. Bedoya's NPI, 1811134158, was assigned on January 8, 2009. Dr. Bedoya holds Alabama license 31555.

NPI and contact details
Medicare PAC ID
5799940607
NPI enumeration date
January 8, 2009
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(256) 705-4224
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
49
Medical school graduation
2003

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Diego Jacinto Bedoya practices at Clearview Cancer Institute in Huntsville, Alabama

Dr. Bedoya's primary practice is Clearview Cancer Institute, at 3601 Cci Dr Nw, Huntsville, AL 35805-2606. The practice phone is (256) 705-4224.

  • Clearview Cancer Institute
    3601 Cci Dr Nw, Huntsville, AL 35805-2606Phone(256) 705-4224

Source: Dmand AI Affiliation Data

Dr. Diego Jacinto Bedoya is affiliated with 5 sites of care and 1 medical group

Dr. Bedoya's primary practice is Clearview Cancer Institute in Huntsville, Alabama. Dr. Bedoya is also affiliated with Huntsville Hospital. The medical group on file is Clearview Cancer Institute. Dmand AI also links Dr. Bedoya to 3 more hospitals, each named with a free account.

See all 6 affiliations for Dr. Bedoya

Source: Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Diego Jacinto Bedoya's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bedoya practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Clearview Cancer InstituteAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Bedoya practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Diego Jacinto Bedoya is one of 169 hematologists and oncologists in Alabama

Hematology and oncology is Dr. Bedoya's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Bedoya's licenses on file in 2 states: Alabama and Texas.

Specialties and state licenses

  • Hematology and oncology, AlabamaPrimaryLicense 31555 · taxonomy 207RH0003X
  • Internal medicine, TexasLicense BP10024883 · taxonomy 207R00000X

Hematologists and oncologists near Dr. Bedoya

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Diego Jacinto Bedoya billed Medicare for 55,601 services in 2024

CMS data shows 55,601 Medicare services from Dr. Bedoya across 74 procedure codes in 2024, for 985 Medicare patients. Medicare paid $1,127,120 for them.

Medicare services, 202455,601
Medicare patients985
Paid by Medicare$1.1M
Procedure codes74

Dr. Bedoya's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Drugs given in the office
2023: 88,2832024: 39,76455%
Lab and pathology
2023: 10,5162024: 9,9545%
Surgery
2023: 1,9592024: 1,8446%
Tests and treatments
2023: 2,4842024: 1,78128%
Office and hospital visits
2023: 1,4672024: 1,4751%
Other services
2023: 4932024: 78359%

Where Dr. Bedoya's Medicare services took place, 2024

  • In an office55,508100%
  • In a facility930%

Dr. Bedoya compared with the Alabama median for hematologists and oncologists, 2024

  • Dr. Bedoya
  • Alabama median
Medicare services
55,601vs 1,22445.4 times
Medicare patients
985vs 2823.5 times
Part D claims
1,859vs 8462.2 times

Medians across 162 hematologists and oncologists in Alabama with Dmand AI profiles that report each measure.

Dr. Bedoya's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Bedoya

Need commercial claims for Dr. Bedoya?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Bedoya and other hematologists and oncologists in Alabama.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Diego Jacinto Bedoya treated 985 Medicare patients in 2024, average age 75

CMS counts 985 Medicare patients who saw Dr. Bedoya in 2024. The largest group is 75 to 84, with 387 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bedoya's median patient age at 67, with 64% women.

Medicare patients, 2024985
Average age75
Average risk score1.83
Also on Medicaid10%

Dr. Bedoya's Medicare patients by age, 2024

Dr. Bedoya's Medicare patients by sex, 2024

  • Women57158%
  • Men41442%

Chronic conditions among Dr. Bedoya's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Arthritis55%
  4. Diabetes39%
  5. Cancer37%
  6. Chronic kidney disease37%
  7. Ischemic heart disease36%
  8. Mood disorders28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Bedoya's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women64%
  • Men35%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Diego Jacinto Bedoya wrote 2,364 Medicare Part D claims in 2024

In 2024, Dr. Bedoya wrote 2,364 Medicare Part D claims for 330 patients. 73% of them were for generic drugs. CMS names the drug for 1,859 of them, across 51 drugs with 11 or more claims each, at $3,723,009 in total drug cost. In 2023, CMS named 1,720 claims across 47 drugs.

Part D claims, 20242,364
Drugs named by CMS51
Total drug cost$3.7M
Part D patients330

Dr. Bedoya's Part D claims by kind of drug, 2024

  • Generic1,721 claims73%
  • Brand-name and other643 claims27%

Dr. Bedoya's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Bedoya's Part D claims, 2024

  • Opioids13%298 of 2,364 claims
  • Antibiotics2%47 of 2,364 claims
  • Antipsychotics, patients 65 and over0%11 of 2,364 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,7202024: 1,8598%

Drugs named by CMS: 51 in 2024, 47 in 2023.

See all prescribing by Dr. Bedoya

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Diego Jacinto Bedoya scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bedoya for performance year 2024, reported as part of a group. Dr. Bedoya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Bedoya's MIPS scores, performance year 2024

  • 100of 100Final score
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Bedoya by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Diego Jacinto Bedoya received $5,481 in industry payments from 2016 to 2025

CMS Open Payments shows 251 general payments to Dr. Bedoya from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Novartis Pharmaceuticals Corporation paid the most, $692.

General payments to Dr. Bedoya by program year, 2016 to 2025

General payments to Dr. Bedoya by kind, 2016 to 2025

$5.5Kin total
  • Food and beverage$4,06974%
  • Grants$5019%
  • Device or supply loans$4328%
  • Education$3597%
  • Speaker and faculty fees$1202%

Companies that paid Dr. Bedoya the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Bedoya

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Diego Jacinto Bedoya's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Diego Jacinto Bedoya

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Diego Jacinto Bedoya's NPI number?

Dr. Diego Jacinto Bedoya's NPI number is 1811134158. It was assigned on January 8, 2009, and it is active in the NPI Registry.

What kind of doctor is Dr. Diego Jacinto Bedoya?

Dr. Diego Jacinto Bedoya is a hematologist and oncologist in Huntsville, Alabama. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Diego Jacinto Bedoya practice?

Dr. Bedoya practices at 3601 Cci Dr Nw, Huntsville, AL 35805-2606. Dr. Bedoya's primary practice is Clearview Cancer Institute in Huntsville, Alabama. Dmand AI also links Dr. Bedoya to 3 hospitals.

What is Dr. Diego Jacinto Bedoya's office phone number?

The practice phone on file for Dr. Bedoya is (256) 705-4224.

What is Dr. Diego Jacinto Bedoya's medical license number?

Dr. Bedoya holds Alabama license 31555, one of the licenses on file in 2 states.

Which states has Dr. Diego Jacinto Bedoya been licensed in?

Dmand AI has state licenses on file for Dr. Bedoya in Alabama and Texas.

Which hospitals is Dr. Diego Jacinto Bedoya affiliated with?

Dr. Bedoya is affiliated with Huntsville Hospital. Dmand AI links Dr. Bedoya to 3 more hospitals.

What medical group is Dr. Diego Jacinto Bedoya part of?

Dr. Bedoya is linked to Clearview Cancer Institute.

Does Dr. Diego Jacinto Bedoya accept Medicare?

Yes. CMS data shows Dr. Bedoya billed Medicare for 55,601 services in 2024, and Dr. Bedoya accepts Medicare assignment.

What is Dr. Diego Jacinto Bedoya's MIPS score?

Dr. Bedoya's MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.

Show 5 more questionsShow fewer questions

How many Medicare patients does Dr. Diego Jacinto Bedoya see?

CMS counts 985 Medicare patients who saw Dr. Bedoya in 2024, with an average age of 75.

What services does Dr. Diego Jacinto Bedoya bill to Medicare?

In 2024, Dr. Bedoya's most billed Medicare services were injected or infused drug (J0881), injected or infused drug (J0897) and injected or infused drug (J9271).

What drugs does Dr. Diego Jacinto Bedoya prescribe most?

In 2024 Medicare Part D data, Dr. Bedoya's most prescribed drugs by claims were Eliquis, Hydrocodone-Acetaminophen and Letrozole.

Has Dr. Diego Jacinto Bedoya received payments from drug or device companies?

CMS Open Payments shows $5,481 in general payments to Dr. Bedoya from 45 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Diego Jacinto Bedoya been practicing?

Dr. Bedoya graduated from medical school in 2003, 23 years ago.

Selling to hematology and oncology practices?

See hematologists and oncologists in Alabama by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)